Once again, a certain pharmaceutical and drug supply chain has become highly visible for shortages of critical life-saving medicine. This time, the causes relate to natural disaster, federal government response, and industry-wide manufacturing and distribution practices.
Supply Chain Disruption
Supply Chain Matters concludes the series for self-scoring each of the 2017 Predictions for Industry and Global Supply Chains published at the beginning of this year. In this Part Six final update, we revisit our industry-specific predictions related to B2C and Retail, Apparel and Footwear, Pharmaceutical and Drug supply chains.
Supply Chain Matters continues with succinct update to readers on business and industry headline developments concerning the unprecedented series of catastrophic natural events that have impacted the Caribbean, Mexico and North America.
Supply Chain Matters shares additional information regarding the pharmaceutical and drug industry impacts from the catastrophic impacts of Hurricane Maria that struck the island of Puerto Rico over three weeks ago.
Supply Chain Matters highlights some initial pharmaceutical and drug industry supply chain impacts concerning the catastrophic effects of Hurricane Maria on the nation of Puerto Rico.
Supply Chain Matters through its social media voice, is appealing to non-profit disaster response agencies, governments, cities, individual companies and supply chain services firms to volunteer what you can in services and expertise to the government of Puerto Rico in its time of need.